Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study.
- DOI
- 10.1016/j.esmoop.2026.106907
- Published
- 2026 Apr
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2026.106907,
title = {Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study.},
author = {Moik F and Huemer F and Doleschal B and Taghizadeh H and Reimann P and Kostmann SM and Wagner L and Abdel Hamid M and Zimmer KC and Suppé SA and Bachleitner C and Schaberl-Moser R and Amann A and Wolf D and Greil R and Jost PJ and Winder T and Rumpold H and Weiss L and Gerger A and Seeber A and Riedl JM},
year = {2026},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2026.106907},
url = {https://doi.org/10.1016/j.esmoop.2026.106907}
}RIS
TY - JOUR TI - Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study. AU - Moik F AU - Huemer F AU - Doleschal B AU - Taghizadeh H AU - Reimann P AU - Kostmann SM AU - Wagner L AU - Abdel Hamid M AU - Zimmer KC AU - Suppé SA AU - Bachleitner C AU - Schaberl-Moser R AU - Amann A AU - Wolf D AU - Greil R AU - Jost PJ AU - Winder T AU - Rumpold H AU - Weiss L AU - Gerger A AU - Seeber A AU - Riedl JM PY - 2026 JO - ESMO open DO - 10.1016/j.esmoop.2026.106907 UR - https://doi.org/10.1016/j.esmoop.2026.106907 ER -
APA
F, M., F, H., B, D., H, T., P, R., SM, K., L, W., M, A. H., KC, Z., SA, S., C, B., R, S., A, A., D, W., R, G., PJ, J., T, W., H, R., L, W., A, G., A, S., & JM, R. (2026). Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study.. ESMO open. https://doi.org/10.1016/j.esmoop.2026.106907
Source records
- pubmed · retrieved 2026-09-27T15:00:59.704Z